Skip to content

EFFECTIVENESS OF COPPER DRESSINGS IN CAESAREAN WOUND HEALING

EFFICACY OF COPPER IMPREGNATED WOUND DRESSING FOR WOUND HEALING IN REPEAT CAESAREAN DELIVERY : A PILOT STUDY - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090502
Enrollment
100
Registered
2025-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Copper dressing: For group A (Copper impregnated wound dressing group) After skin closure of repeat caesarean section, Copper impregnated wound dressing will be applied for 7 days. Cont

Sponsors

Med Cu Technologies Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women of any age and parity with gestational age more than 28 weeks and undergoing repeat caesarean section, either emergency or elective. Patients who are willing to follow up in UCMS & GTB Hospital

Exclusion criteria

Exclusion criteria: Patients with Hepatitis B Hepatitis C HIV or Syphilis. Patients with any dermatological condition around the surgical site Patients allergic to Copper or Wilson s Disease. Any acute febrile illness.

Design outcomes

Primary

MeasureTime frame
Measure: Mean REEDA (Redness, Edema, Ecchymosis, Discharge, Approximation) score in both the groups on day 7, day 10 and day 30.Timepoint: Measure: Mean REEDA (Redness, Edema, Ecchymosis, Discharge, Approximation) score in both the groups on day 7, day 10 and day 30.

Secondary

MeasureTime frame
Incidence of SSI among both the groups. Length of hospital stay. Readmission & resuturing rates due to wound comorbidities like discharge, gape etc. in both the groups. Side effect of using copper impregnated dressings such as erythema, itching, edema, etc. Comorbidities associated with wound complications.Timepoint: End of the trial

Countries

India

Contacts

Public ContactDr. Swarnima Agrawal

University college of medical Sciences and GTB hospital

gautamdrricha1@gmail.com7011484180

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026